+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Maxalt"

From
Maxalt - API Insight, 2022 - Product Thumbnail Image

Maxalt - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Maxalt- Drug Insight, 2019 - Product Thumbnail Image

Maxalt- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Maxalt is a brand of analgesic drug used to treat migraine headaches. It is a selective serotonin receptor agonist, which works by narrowing blood vessels around the brain and reducing substances in the body that can trigger migraine symptoms. Maxalt is available in both oral and nasal spray forms, and is typically taken at the onset of a migraine attack. It is one of the most commonly prescribed migraine medications in the United States. Maxalt is part of a larger market of analgesics, which are drugs used to relieve pain. Analgesics are divided into two main categories: non-opioid and opioid. Non-opioid analgesics, such as Maxalt, are typically used to treat mild to moderate pain, while opioid analgesics are used to treat more severe pain. Some of the companies in the Maxalt market include Merck & Co., Inc., GlaxoSmithKline, and Novartis. Show Less Read more